The production of Mortierella alpina oil, rich in arachidonic acid (ARA), involves a process of aerobic fermentation. This process is highly dependent on oxygen supply due to the low solubility of oxygen in the fermentation broth. To address this, specialized gas distributors are used to enhance oxygen delivery. For instance, perforated ring gas distributors and novel microporous ceramic membrane gas distributors have been designed to improve oxygen supply, leading to increased dry cell weight, lipid concentration, and ARA content in the fungal biomass. The use of a membrane gas distributor, in particular, has shown significant improvements, with optimal results achieved when the dissolved oxygen level is controlled at around 40%[1].
The fermentation process typically involves growing the Mortierella alpina fungus on a suitable carbon source, such as glucose. The fungus accumulates lipids within its hyphae, which can account for up to 50% of its dry weight. These lipids are primarily in the form of triacylglycerols, with a high content of ARA. The fermentation is carried out under controlled conditions to optimize lipid production and ARA content. Once the fermentation is complete, the microbial oil is extracted and processed to meet the required specifications for use in products such as infant formulas, nutraceuticals, and health foods. The oil produced is characterized by a high weight percentage of ARA, particularly at the Sn-2 position of the triglyceride, which enhances its absorption and utilization in the human body[2][3].
The safety profile for human consumption of Mortierella alpina oil, particularly the arachidonic acid (ARA)-enriched oil derived from it, is well-established through extensive toxicological and safety studies. The oil has been subjected to various safety assessments, including gene mutation assays, chromosome aberration assays, and acute and subacute oral toxicity studies in rats, which have shown no mutagenic or clastogenic activity and no significant toxicity even at high doses[1][2][3]. The oil is produced from non-pathogenic and non-genetically modified strains of Mortierella alpina, and it does not produce mycotoxins or other harmful substances under production conditions. The oil has been approved for use in infant and follow-on formulas, and numerous animal studies have confirmed its safety, establishing a no-observed-adverse-effect level (NOAEL) that is significantly higher than the intended human intake[1][2][3].
Regarding potential contamination risks, the production of Mortierella alpina oil is tightly regulated to ensure minimal exposure to harmful substances. Batch analyses have consistently shown that the oil complies with regulatory limits for heavy metals such as lead, cadmium, mercury, and arsenic[4][3]. The extraction process uses hexane, but this solvent is not detected in the final product. Additionally, the oil is checked for other potential contaminants including benzo(a)pyrene, dioxins, pesticide residues, acrylamide, and mycotoxins, with no concerns identified[4]. The production process adheres to HACCP principles and GMP standards, further minimizing the risk of contamination. There are no indications of heavy pesticide use in the cultivation of Mortierella alpina, as it is a fungus grown in controlled fermentation environments rather than in agricultural settings[2]. Overall, the rigorous testing and production standards ensure that the oil is free from significant contamination risks.
Hundreds of ingredients are entering the US food supply every year. Not to mention, the hundreds of tainted products with unlabled toxic contaminiants. Join so you can shop with ease of mind.